Skip to main content

AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.

With a feed capacity of 30kg/h (max 50kg/h), the state-of-the-art unit has been designed to handle a wide range of API including HAPI compounds with OEB 4 (OEL band 1-10µg/m3).

The micronizer equipment is a Hosokawa Alpine Multi-Mill, with a dual system which enables wider applications.

The project denominated “Implementation of a new micronization technology for the expansion and diversification of the site capacity” (file nº: ACE002/20/000031) was partially financed by funds from ACCIÓ – Catalonia Trade & Investment of the Generalitat de Catalunya.

The new capability will provide higher flexibility and will offer our customers a complete process integration for their projects.

Contact us for more information.

Latest News

Market InsightsJun Kurihara new CEO of AGC Pharma Chemicals
4th June 2025

Jun Kurihara new CEO of AGC Pharma Chemicals

AGC Pharma Chemicals announces the appointment of Jun Kurihara as its new Chief Executive Officer, effective June 1, 2025. Kurihara, who currently serves as Executive Vice President, has extensive experience…
Events & ConventionsAGC Pharma Chemicals to join BOS Basel 2025
27th May 2025

AGC Pharma Chemicals to join BOS Basel 2025

AGC Pharma Chemicals is pleased to confirm its participation in BOS Basel 2025, taking place on June 11–12. This event, organized by Bio2Business, is a leading networking platform for biopharma…
Events & ConventionsAGC Pharma Chemicals to attend the European Pharma Outsourcing Summit 2025
26th May 2025

AGC Pharma Chemicals to attend the European Pharma Outsourcing Summit 2025

AGC Pharma Chemicals will be attending the European Pharma Outsourcing Summit (EPOS) on June 5–6, where we will be exhibiting at Booth 17. This summit is recognized as a strategic…